Comments
Loading...

BioStem Technologies

BSEMOTCPK
Logo brought to you by Benzinga Data
$13.92
0.433.20%
At close: -
Consensus Rating1
Buy
Highest Price Target1
$6.40
Lowest Price Target1
$6.40
Consensus Price Target1
$6.40

BioStem Technologies (OTC:BSEM) Stock, Analyst Ratings, Price Targets, Forecasts

BioStem Technologies Inc has a consensus price target of $6.4 based on the ratings of 1 analysts. The high is $6.4 issued by Zacks Investment Research on November 7, 2022. The low is $6.4 issued by Zacks Investment Research on November 7, 2022. The 1 most-recent analyst ratings were released by Zacks Investment Research on November 7, 2022, respectively. With an average price target of $6.4 between Zacks Investment Research, there's an implied -54.03% downside for BioStem Technologies Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Zacks Investment Research

1calculated from analyst ratings

Analyst Ratings for BioStem Technologies

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for BioStem Technologies (BSEM) stock?

A

The latest price target for BioStem Technologies (OTCPK:BSEM) was reported by Zacks Investment Research on November 7, 2022. The analyst firm set a price target for $6.40 expecting BSEM to fall to within 12 months (a possible -54.03% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for BioStem Technologies (BSEM)?

A

The latest analyst rating for BioStem Technologies (OTCPK:BSEM) was provided by Zacks Investment Research, and BioStem Technologies initiated their buy rating.

Q

When was the last upgrade for BioStem Technologies (BSEM)?

A

There is no last upgrade for BioStem Technologies

Q

When was the last downgrade for BioStem Technologies (BSEM)?

A

There is no last downgrade for BioStem Technologies.

Q

When is the next analyst rating going to be posted or updated for BioStem Technologies (BSEM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioStem Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioStem Technologies was filed on November 7, 2022 so you should expect the next rating to be made available sometime around November 7, 2023.

Q

Is the Analyst Rating BioStem Technologies (BSEM) correct?

A

While ratings are subjective and will change, the latest BioStem Technologies (BSEM) rating was a initiated with a price target of $0.00 to $6.40. The current price BioStem Technologies (BSEM) is trading at is $13.92, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.